See the DrugPatentWatch profile for Dovato
Dovato is a prescription medication used to treat HIV-1 infection in adults and adolescents [1]. The price of Dovato can vary significantly based on factors such as insurance coverage, pharmacy, and location [2].
How much does Dovato cost without insurance?
Without insurance, a 30-day supply of Dovato can range from approximately $3,000 to $4,000 or more [2]. This price is for the drug itself and does not include any associated medical services.
Can I get financial assistance for Dovato?
Pharmaceutical manufacturers often offer patient assistance programs for their medications. For Dovato, eligible patients may be able to access financial support through the Dovato Savings Card program or other programs offered by the manufacturer, ViiV Healthcare [3]. These programs can help reduce out-of-pocket costs for commercially insured patients [3]. Eligibility criteria and program details can be found on the manufacturer's website.
How does insurance affect Dovato pricing?
Insurance coverage plays a critical role in determining the out-of-pocket cost of Dovato. Most insurance plans, including Medicare and Medicaid, cover prescription drugs, but the extent of coverage and co-payment amounts differ. Patients with insurance may pay a significantly lower price, often a co-pay set by their plan, which can range from a few dollars to hundreds of dollars per month [2]. It is advisable to check with your insurance provider for specific coverage details and co-payment information.
What is the active ingredient in Dovato and does it have generics?
Dovato is a combination medication containing dolutegravir and lamivudine [1]. As of late 2023, there are no generic versions of Dovato available. Drug patents protect the formulation and active ingredients, and generic competition typically emerges after patent expiry [4].
When will generic versions of Dovato be available?
The availability of generic versions of Dovato depends on patent expiry dates and any potential patent litigation. Information on drug patents and exclusivity periods can be found on resources like DrugPatentWatch.com [4]. The timeline for generic entry can vary widely and is subject to legal challenges.
How does Dovato compare to other HIV medications in terms of cost?
The cost of HIV medications is a significant consideration for patients. Dovato, being a single-tablet regimen with newer active ingredients, may be priced comparably to other integrated therapies. However, the cost landscape for HIV treatment is diverse, with older medications or those with established generic alternatives generally being less expensive [2]. Comparing specific treatment regimens requires looking at the co-pays and overall cost associated with each drug and its respective insurance coverage.